© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Sulfadiazine came along in the 1930s, during a time when bacterial infections threatened lives far more than today. Early researchers scrambled for ways to combat deadly pathogens, and the sulfonamide group soon became a base for antibiotic discovery. Prontosil, the original red dye that kicked off the age of antibiotics, gave chemical inspiration. Scientists kept digging, trimming molecular structures until they carved out sulfadiazine, which offered a broader range and stronger punch against both gram-positive and gram-negative bacteria. Once doctors began putting it to use, deaths from common infections like pneumonia and dysentery started dropping. Field hospitals in World War II carried it for soldiers' wounds, saving countless lives. Decades later, it still finds a place in hospitals, shelter medicine, and out in rural clinics. All this history gives context to why understanding sulfadiazine matters today.
What people pick up in a vial or a blister pack labeled "sulfadiazine" is a white or nearly white crystalline powder. It dissolves slightly in water, so it usually comes as tablets or sometimes as a cream, especially for burns. Its structure is part of the sulfonamide family, which means it fights infections by blocking bacterial folic acid synthesis. This puts the brakes on bacteria’s ability to multiply and spread. You’ll see sulfadiazine paired with other antibiotics for synergy, especially when pathogens get tricky. The drug keeps cropping up on hospital shelves and sometimes in vet clinics, proving its staying power among older antibiotics.
Sulfadiazine has a molecular formula of C10H10N4O2S, with a molecular weight just over 250 g/mol. The powder is almost odorless, with a slight bitter taste. It melts between 250°C and 255°C, so it stands up to moderate heat during processing. Solubility is low in water (less than 0.7 mg/mL), which shapes how pharmacists formulate it. Chemically, it’s a sulfonamide, sitting on a pyrimidine ring. That arrangement gives it both the magic and the limits of older sulfa antibiotics. The molecule doesn’t break down fast in dry conditions but reacts with strong acids or bases. Handling it doesn’t feel different than other fine powders, but inhaling the dust isn’t safe, so proper masks matter in production.
Pharmaceutical-grade sulfadiazine carries a purity level above 99%, tested for related substances and residual solvents. Labels specify batch number, expiry date, purity percentage, and storage conditions. Tablets may carry dosages from 250 mg to 500 mg; topical creams pull sulfadiazine into silver salts for faster skin absorption. Quality standards run tight under pharmaceutical compendia like the USP and the European Pharmacopoeia. This strict framework gives confidence to prescribers and patients that what’s in the bottle works and won’t poison anyone.
Industrial synthesis starts with sulfanilamide. Chemists react it with cyanamide under pressure and heat, forging a key carbon-nitrogen bond. After cooling, solvents strip out unwanted chemicals, and filtration separates crystals from the liquid leftovers. Purity demands a careful eye on temperature, timing, and pH. Once the crude product dries, additional steps wash out pigments and byproducts. The final product arrives as a fine powder, ready for packaging or further processing into finished drugs. Some plants recycle solvents and caustics, shrinking both cost and waste streams.
Sulfadiazine’s core structure opens possibilities for making derivatives. Adding a silver ion, for example, creates silver sulfadiazine – a game-changer for burn treatment. Heavy heat or strong alkaline solutions can cause sulfonamide bonds to snap, breaking down its antibiotic power. Under laboratory conditions, researchers sometimes attach sulfadiazine to polymers, hoping for new forms that release medicine slower or target infection sites more precisely. Small chemical tweaks also shift its solubility, which could make it easier for patients to take. While the original molecule stays front and center, innovations build on its back.
Pharmacists and manufacturers have tagged sulfadiazine with many names. Its trade names include Microsulfon, Silvadene (for the silver salt), and Sulfadiazine Sodium when prepared as a salt. In Europe or Asia, products may show brand or generic names depending on registry and regulations. Chemical synonyms sometimes pop up in scientific publications: N1-(2-pyrimidinyl)sulfanilamide or 4-Aminobenzenesulfonamide, N1-2-pyrimidinyl. This data guides doctors and researchers searching for studies or supply sources.
Manufacturing and handling sulfadiazine demands strict standards to avoid cross-contamination and exposure. Production lines use closed systems, and staff wear gloves, lab coats, and respirators. In clinical use, allergies rank as the biggest safety concern. Sulfa allergies cause rashes, fever, and in the worst cases, life-threatening skin reactions like Stevens-Johnson syndrome. Regular checks keep manufacturing facilities in line with FDA and EMA requirements. Storage stays cool and dry, with good airflow to stop dust buildup or clumping. Training for anyone working along the supply chain lays ground rules for safe handling and prompt response to spills or exposures.
Doctors rely on sulfadiazine's bacteria-blocking skills to treat certain infections. It treats urinary tract infections, some meningitis cases, and even toxoplasmosis, a tough infection caused by a parasite. In burn units, silver sulfadiazine has a well-earned place, slathered on wounds to curb infection risk and speed healing. Veterinary clinics keep it handy for treating bacterial infections in livestock and pets. Its reach crosses human and animal medicine, stretching from city hospitals to field clinics in remote regions, due to low cost and proven results.
Research keeps finding fresh uses for an old drug. Laboratories all over the world test sulfadiazine’s effectiveness against emerging threats, trying it in new combinations where newer drugs fall short. Scientists focus on tweaking the structure to dodge bacterial resistance, boost potency, or improve absorption. New delivery methods, such as nanoparticles or polymer-bound versions, aim for slower release and fewer side effects. Some researchers in cancer fields investigate its use, not as an antibiotic, but as a way to help chemotherapy drugs work better. Despite age, this molecule refuses to leave center stage in the fight against disease.
Every batch of sulfadiazine goes through rigorous testing for safety. Animal studies mapped out how it spreads through the body, how fast organs break it down, and where it might build up. Chronic exposure studies show that the kidneys handle most elimination, which makes careful monitoring necessary for patients with kidney disease. High doses cause blood count changes, crystal formation in urine, sometimes leading to stones or acute kidney injury if unchecked. Allergic reactions remain a top concern in clinics, so health workers screen patients for sulfa sensitivity before prescribing anything. Over decades of use, the medical literature picks apart every rare side effect and edge case, helping doctors make safer decisions and sparking ideas for improving the drug.
The world keeps looking for antibiotics that still work as resistance rates jump. While sulfadiazine comes from an older era, it may offer building blocks for next-generation drugs. Blending sulfadiazine with new delivery systems—like targeted nanoparticles or smart hydrogels—could cut dosing schedules and lower side effects. Countries working with tight healthcare budgets turn to it when newer drugs become scarce or unaffordable, keeping sulfadiazine relevant. Expanding its use in veterinary and agricultural fields opens further markets, though stewardship remains key to prevent resistance from spilling into the food chain. Training programs for safe use, regular monitoring for allergic reactions, and research on better administration methods will guide its journey in the years ahead. Its past shapes its future, in medicine cabinets and research labs across the globe.
Sulfadiazine doesn’t usually earn headlines, but it plays a vital role behind the scenes in medicine and animal health. Doctors keep it in their toolbox for a good reason. This medication, discovered in the 1930s, belongs to the sulfonamide group—one of the earliest families that stopped deadly infections before the age of penicillin.
Toxoplasmosis remains a disease that can devastate people with weak immune systems. Pregnant women face real risks if exposed. Sulfadiazine, especially in combination with pyrimethamine, forms part of the standard treatment to destroy Toxoplasma gondii, a tricky parasite. The Centers for Disease Control and Prevention include sulfadiazine in their guidance because it consistently works where newer drugs can fall short. Reduced access could mean more severe illness, more hospital time, and, for some, threat to life.
Burn wards count on silver sulfadiazine cream to reduce infection risk in patients with serious burns. The pain might hit first, but infections regularly cause long-term disability and even death. Silver sulfadiazine’s broad coverage can save skin and prevent microbes from turning injuries into lifelong problems.
As a rural kid, I saw local hospitals deal with bacterial outbreaks by rotating older antibiotics like sulfadiazine. Overuse of new drugs breeds resistance—today’s miracle pill becomes tomorrow’s useless pill if used carelessly. Many hospitals now use sulfadiazine to limit this risk, reserving stronger drugs for emergencies. According to the World Health Organization, antibiotic resistance stands as a public health crisis, and preserving drug variety means keeping infections treatable.
Livestock need attention too. Vets regularly prescribe this antibiotic for respiratory, gastrointestinal, and urinary tract infections in animals. Quick access helps small farmers avoid widespread losses. Food safety agencies watch its use to protect both animals and, through the food chain, people. Without older antibiotics as tools, animal health and farm stability would take a hit, which brings food costs up for everyone.
All medications carry some baggage, and sulfadiazine isn’t an exception. Allergic reactions, kidney stones, and anemia can wreck a recovery if folks or professionals ignore dosing or ignore symptoms. Keeping track through regular blood work and clear patient education keeps complications low. Responsible use sits at the center of safe and effective care. Health professionals keep sulfadiazine as a sharp tool, not a cure-all, and rotate it with other antibiotics to prevent resistance.
Research still backs careful, targeted use. Public health groups push for stewardship—giving the drug only when necessary and tracking patterns of resistance. Simple steps from government and hospitals—like updating guidelines, offering refresher training to health workers, and funding studies into resistance trends—can keep this old antibiotic working for future generations.
Sulfadiazine works as an antibiotic, often used for treating infections like urinary tract infections, burn wounds, and even some types of pneumonia. This drug belongs to the sulfa family—the same group that’s saved lives since penicillin was still just a lab experiment. Working in healthcare, I've seen it prescribed to people of all ages, with different backgrounds and health issues. Even though it can be effective, sulfadiazine often brings its share of problems. Knowing what to expect makes it easier to spot when things are going off track.
One thing that stands out with sulfadiazine is upset stomach. Nausea and vomiting usually show up within the first few days. Some patients tell me they feel queasy after every dose, so eating before taking it can help. Diarrhea comes up more than you’d think and needs to be watched—no one wants to end up dehydrated or sicker than before. I’ve also heard plenty of people mention a weird, metallic taste that lingers long after the medicine goes down.
Rashes tend to bother many people. These don’t always start as full-blown allergic reactions; sometimes, a light pink rash breaks out on the arms or chest. If it spreads or starts to itch a lot, doctors want to know about it. Some rashes turn serious—like Stevens-Johnson syndrome—which demands immediate care to avoid severe skin and tissue damage.
Sometimes I've noticed folks complain of headaches, dizziness, or even feeling unusually tired. These side effects disrupt daily routines more than people expect. Being off-balance or too tired to work shifts or care for kids isn’t just annoying—it can lead to accidents or strained relationships if left unchecked.
Some lab technicians see a drop in white blood cells, or changes in blood counts. Sulfadiazine can set off signs of anemia, which makes people feel wiped out and short of breath doing simple things like walking the stairs. Keeping up with regular blood tests isn’t just doctor’s busywork—it can spot bigger problems before they get out of hand.
In my experience, side effects ramp up in people who already have kidney or liver problems, or those with a history of sulfa allergies. It's important to talk to a doctor before starting this medicine, especially for people who take other drugs. Combining sulfadiazine with blood thinners or drugs for diabetes, for example, cranks up risks for bleeding or low blood sugar. Pregnant women and babies under two months old should be extra cautious since their bodies handle medicines differently.
No one likes to stop a medicine that’s supposed to fix an infection, but calling the doctor at the first sign of trouble beats waiting until side effects snowball. Doctors often have similar antibiotics standing by, ones that won’t trigger allergies or upset the stomach so much. Taking each pill with food, drinking more water, and reporting new symptoms right away keeps minor woes from becoming emergencies.
The most important thing—don’t ignore your body’s signals. Research from trusted sources like Mayo Clinic and reputable universities continues to show that understanding the risks and benefits of each medicine leads to safer, smarter choices. Anyone who feels off during treatment should seek help sooner, not later. That’s how patients can stay in control and keep the focus on healing, not just enduring side effects.
Sulfadiazine might seem straightforward, just another pill doctors hand out for infections. There's more to it than just grabbing the bottle and swallowing a tablet. Doctors reach for it because it can tackle tough bacteria, the kind that won’t budge for lesser drugs. Misusing an antibiotic like this doesn’t just risk your own health. It pushes bacteria to get clever, grow stronger, and sometimes turn deadly.
Every prescription tells a story: the dose, how often to take it, what to avoid. The details may take work to remember, but I’ve seen friends bounce back fast from infection by sticking to the instructions, even if they felt fine by the third day. The reality is that stopping too soon, skipping doses, or sharing the medicine could leave some bacteria lurking in the body, ready to strike again. This leads to relapse, longer illness, and the risk of spreading tough bugs around.
Doctors and pharmacists both say: take sulfadiazine with a full glass of water. This helps protect the kidneys and clears the drug out of the body. A lot of folks reach for milk to wash down pills. With sulfa drugs, milk can change the way the body absorbs the medicine. Water is the safe choice.
People tend to think common antibiotics always play nice. My own family has learned that older medicines like sulfadiazine can hit hard with side effects if ignored. Rashes, fever, or joint aches mean picking up the phone and calling a doctor. Drinking extra water helps prevent kidney stones, a real risk if the drug crystals slow down inside the body. Nausea sometimes pops up, but serious reactions need quick attention. Knowing the signs keeps things from getting worse.
Everyone has forgotten a pill at least once. Skipping a dose with sulfadiazine throws off the delicate balance needed to beat infection. Setting a timer, using a pill organizer, or marking off a calendar can help keep things on track. Some people fear antibiotics, thinking they’re too strong or unnecessary. Trust the expertise behind the prescription. Taking every dose—not just most—brings a higher chance of a clean recovery.
Sometimes people want a shortcut, splitting pills to make them last or taking only half a dose. This backfires every time. Lower levels in the blood create a breeding ground for resistant bacteria. Any questions about a new symptom or a missed dose should go straight back to the prescriber. Never double up without that green light.
More clinics now use text reminders or smartphone apps to guide patients through their course of antibiotics, making it easier than ever to stick to the plan. Public health campaigns rightly stress not to save leftovers or pass antibiotics to friends. We need open conversations between patients, pharmacists, and doctors about concerns, costs, and alternatives. That honest feedback keeps people healthy and holds back the rise of superbugs.
Sulfadiazine packs serious power but demands respect and careful use. As people become more informed, share facts with friends and family, and stay alert for side effects, it boosts everyone’s shot at staying healthier—today and down the road.
A lot of people see sulfadiazine as just another antibiotic, but in truth, there’s a layer of complexity to its use that often flies under the radar. Doctors prescribe it for serious infections—urinary tract infections, toxoplasmosis, and even some cases of burn wound care. My years watching loved ones navigate treatments show that common antibiotics don’t always come wrapped in simple rules.
Anybody with a known allergy to sulfa drugs needs to avoid sulfadiazine. Allergic reactions can range from annoying rashes to hospital-level emergencies like Stevens-Johnson syndrome. If you’ve had trouble with other sulfa medications, speak up before ever taking this one.
Not all warnings are obvious. People with severe liver or kidney problems can run into trouble because these organs move the drug through the body and clear it out again. Poor function raises the risk of buildup, which can turn toxic. Data in the New England Journal of Medicine and FDA reports both link improper dosing to unwanted side effects when organs aren’t working well.
Conditions like anemia, low white blood cell counts, or other bone marrow problems deserve careful attention. Sulfadiazine can block the production of blood cells. I’ve watched friends living with chronic illnesses juggle multiple prescriptions. They constantly need bloodwork to keep tabs on their levels. When sulfadiazine enters the mix, that effort ramps up.
Pregnant women or new mothers need to be cautious. Sulfadiazine crosses the placenta and enters breast milk. It can bring harm to the baby, especially close to delivery, where it might trigger a buildup of bilirubin that can damage an infant’s brain. The American College of Obstetricians and Gynecologists and the FDA agree. Unless the infection is life-threatening, other medications should get a look first.
Babies under two months fall in a special category of risk. Their bodies can’t handle sulfadiazine well, which can lead to kernicterus, a dangerous brain problem. My neighbor’s newborn spent three days in the hospital for jaundice—a stark illustration of the stakes in real-world terms.
Sulfadiazine doesn’t act alone. Taken with drugs like methotrexate or warfarin, it can alter effectiveness and raise the danger of bleeding or toxicity. There’s no shortcut here. Patients should always give a full account of every pill and supplement. Pharmacists, from the local pharmacy to the hospital ward, can catch problems doctors might miss.
Getting the benefits of sulfadiazine means owning every angle: allergies, underlying health problems, pregnancy, age, and all current medications. Regular bloodwork, personal vigilance for signs of rash, fever, or yellowing skin, and teamwork between patient, doctor, and pharmacist play a make-or-break role. Open communication and careful monitoring build real safety nets. In my own caregiving experience, staying informed never fails to make a difference.
Sulfadiazine, often prescribed for infections like toxoplasmosis, doesn’t stand alone once it enters your body. It has neighbors—other medications you’re taking at the same time. That’s where the story of interaction begins. Most folks taking medications know the basics: read the inserts, talk to your pharmacist, but things get muddy once you’re dealing with drugs in the same system.
Experience shows that a single pill rarely causes problems. Trouble typically pops up with combinations. Take a prescription like sulfadiazine: this drug belongs to the sulfonamide group. It helps by slowing the growth of bacteria, which gives your immune system a boost. If another drug rides along—let’s say the common blood thinner warfarin—the story changes. Both processes can get stronger or weaker. This could mean thinner blood, putting you at a greater risk for bleeding. So one medicine helps, but mixing the two could hurt if you’re not careful.
Sulfadiazine relies on your liver and kidneys to break it down and clear it out. The trouble creeps in when another drug wants to use the same lanes. Methotrexate, for example, also leans on those routes. The body may struggle to handle traffic—medications can slow down, leading to higher levels in your system. This can build up in the wrong ways, turning a helpful dose into a problem.
Antacids, often taken for heartburn, can stick around in the gut and block how sulfadiazine gets absorbed. Some people assume over-the-counter medicines don’t count, but they can easily complicate things.
Sulfadiazine also fights bacteria by targeting folic acid production. Methotrexate, an arthritis medicine, attacks the same target. If both sit in a system, the effect doubles down. People can struggle with low levels of healthy cells that depend on folate, ending up feeling tired or getting mouth sores. Doctors keep an eye out for these warning signs, especially for anyone juggling a complicated daily pill schedule.
People usually want simple answers. The reality: doctors and pharmacists act as quarterbacks. My own experience with family members needing complex care taught me to always ask how medicines play together, not just how they work on their own. You can help the process by sharing a full, honest list of everything you take, including vitamins and herbal supplements. Every detail matters. Routine blood tests aren’t some red tape—they’re how health professionals spot trouble before it gets serious.
Open conversation matters as much as the prescription. Changes to kidney function or liver health can shift the body’s balance, making an old, safe dose suddenly risky. Ask questions. Find out which symptoms signal a problem—rashes, yellowed eyes, unexplained bruising. Reporting side effects early helps prevent bigger issues.
The biggest lesson here: drugs affect each other in ways most people can’t see. Extra care from everyone involved—patients, doctors, pharmacists—means fewer surprises. That’s not just theory. Facts back this up: data from drug monitoring programs show that the right checks, questions, and lab work save lives. No medicine works in isolation, and a well-informed team is the best defense against unwanted effects.
| Names | |
| Preferred IUPAC name | 4-amino-N-pyrimidin-2-ylbenzenesulfonamide |
| Other names |
Sulfadiazinum Sodium sulfadiazine Sulfadiazina Sulfadine |
| Pronunciation | /ˌsʌl.fəˈdaɪ.əˌziːn/ |
| Identifiers | |
| CAS Number | 68-35-9 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Sulfadiazine**: ``` CNc1cc(ccc1S(=O)(=O)N)c2nccs2 ``` |
| Beilstein Reference | 1716596 |
| ChEBI | CHEBI:9359 |
| ChEMBL | CHEMBL20 |
| ChemSpider | 5468 |
| DrugBank | DB00359 |
| ECHA InfoCard | 100.012.144 |
| EC Number | EC 3.5.4.3 |
| Gmelin Reference | 80945 |
| KEGG | C07441 |
| MeSH | D013437 |
| PubChem CID | 5326 |
| RTECS number | XT1575000 |
| UNII | 33T4OJ8Y7N |
| UN number | 3465 |
| Properties | |
| Chemical formula | C10H10N4O2S |
| Molar mass | 250.28 g/mol |
| Appearance | White or almost white, crystalline powder |
| Odor | Odorless |
| Density | 1.49 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 0.20 |
| Vapor pressure | <0.0000001 mmHg (25°C) |
| Acidity (pKa) | 6.5 |
| Basicity (pKb) | 6.71 |
| Magnetic susceptibility (χ) | -64.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.68 |
| Dipole moment | 4.61 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 215.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –81.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -393.8 kJ/mol |
| Pharmacology | |
| ATC code | J01EC10 |
| Hazards | |
| Main hazards | May cause allergic skin reaction; harmful if swallowed, inhaled, or in contact with skin; causes serious eye irritation; may cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Precautionary statements: "P261, P264, P270, P271, P273, P301+P312, P304+P340, P305+P351+P338, P312, P330, P405, P501 |
| Flash point | 181°C |
| Autoignition temperature | 550°C |
| Lethal dose or concentration | LD50 oral rat 2,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 2,000 mg/kg |
| NIOSH | WQ8O9C0O6T |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 200–400 mg/kg per day divided every 6 hours |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Sulfadimidine Sulfamethoxazole Sulfapyridine |
